Authors: KRUIT WH PUNT KJ GOEY SH DEMULDER PH VANHOOGENHUYZE DC HENZENLOGMANS SC STOTER G

Citation: Wh. Kruit et al., CARDIOTOXICITY AS A DOSE-LIMITING FACTOR IN A SCHEDULE OF HIGH-DOSE BOLUS THERAPY WITH INTERLEUKIN-2 AND ALPHA-INTERFERON - AN UNEXPECTEDLYFREQUENT COMPLICATION, Cancer, 74(10), 1994, pp. 2850-2856